John M. Edminson 01/12/2023 John M. Edminson 01/12/2023 EXACT Therapeutics announces successful placement of NOK 25 million share issue Read More John M. Edminson 28/09/2023 John M. Edminson 28/09/2023 EXACT Therapeutics AS announces interim results for first half 2023 Read More John M. Edminson 04/01/2023 John M. Edminson 04/01/2023 Mandatory notification of trade by primary insiders Read More Ragnar Bendiksen 30/09/2022 Ragnar Bendiksen 30/09/2022 Mandatory notification of trade in connection with grant of options to CEO Read More Ragnar Bendiksen 22/09/2022 Ragnar Bendiksen 22/09/2022 EXACT Therapeutics AS announces interim results for first half 2022 Read More Guest User 04/07/2022 Guest User 04/07/2022 EXACT Therapeutics AS - Share Capital Increase Registered Read More Guest User 09/06/2022 Guest User 09/06/2022 EXACT Therapeutics AS – Primary Insider Notice Read More Guest User 09/06/2022 Guest User 09/06/2022 EXACT Therapeutics AS - Notice of Increase in Share Capital Read More Guest User 08/06/2022 Guest User 08/06/2022 EXACT Therapeutics AS announces appointment of Anders Wold as Chair of the Board Read More Guest User 08/06/2022 Guest User 08/06/2022 EXACT Therapeutics AS: Minutes of Annual General Meeting 2022 Read More Guest User 30/05/2022 Guest User 30/05/2022 EXACT Therapeutics AS - Notice of Annual General Meeting 2022 Read More Guest User 23/05/2022 Guest User 23/05/2022 EXACT Therapeutics AS Board Update Read More Guest User 28/04/2022 Guest User 28/04/2022 EXACT Therapeutics AS announces the publication of its 2021 Annual Report Read More Guest User 28/03/2022 Guest User 28/03/2022 EXACT Therapeutics AS Announces Appointment of Dr Per Walday as Chief Executive Officer Read More Guest User 22/12/2021 Guest User 22/12/2021 EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) Read More Guest User 03/12/2021 Guest User 03/12/2021 EXACT Therapeutics AS - EGM minutes Read More Guest User 25/11/2021 Guest User 25/11/2021 EXACT Therapeutics AS - EGM notice Read More Guest User 22/09/2021 Guest User 22/09/2021 EXACT Therapeutics AS announces interim results for first half 2021 Read More Guest User 30/05/2021 Guest User 30/05/2021 Updated: May 30th 2021 — Notice of Annual General Meeting 2021 Read More Guest User 28/05/2021 Guest User 28/05/2021 EXACT THERAPEUTICS ANNOUNCES CLINICAL TRIAL UPDATE Read More Older Posts
John M. Edminson 01/12/2023 John M. Edminson 01/12/2023 EXACT Therapeutics announces successful placement of NOK 25 million share issue Read More
John M. Edminson 28/09/2023 John M. Edminson 28/09/2023 EXACT Therapeutics AS announces interim results for first half 2023 Read More
John M. Edminson 04/01/2023 John M. Edminson 04/01/2023 Mandatory notification of trade by primary insiders Read More
Ragnar Bendiksen 30/09/2022 Ragnar Bendiksen 30/09/2022 Mandatory notification of trade in connection with grant of options to CEO Read More
Ragnar Bendiksen 22/09/2022 Ragnar Bendiksen 22/09/2022 EXACT Therapeutics AS announces interim results for first half 2022 Read More
Guest User 04/07/2022 Guest User 04/07/2022 EXACT Therapeutics AS - Share Capital Increase Registered Read More
Guest User 09/06/2022 Guest User 09/06/2022 EXACT Therapeutics AS - Notice of Increase in Share Capital Read More
Guest User 08/06/2022 Guest User 08/06/2022 EXACT Therapeutics AS announces appointment of Anders Wold as Chair of the Board Read More
Guest User 08/06/2022 Guest User 08/06/2022 EXACT Therapeutics AS: Minutes of Annual General Meeting 2022 Read More
Guest User 30/05/2022 Guest User 30/05/2022 EXACT Therapeutics AS - Notice of Annual General Meeting 2022 Read More
Guest User 28/04/2022 Guest User 28/04/2022 EXACT Therapeutics AS announces the publication of its 2021 Annual Report Read More
Guest User 28/03/2022 Guest User 28/03/2022 EXACT Therapeutics AS Announces Appointment of Dr Per Walday as Chief Executive Officer Read More
Guest User 22/12/2021 Guest User 22/12/2021 EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) Read More
Guest User 22/09/2021 Guest User 22/09/2021 EXACT Therapeutics AS announces interim results for first half 2021 Read More
Guest User 30/05/2021 Guest User 30/05/2021 Updated: May 30th 2021 — Notice of Annual General Meeting 2021 Read More
Guest User 28/05/2021 Guest User 28/05/2021 EXACT THERAPEUTICS ANNOUNCES CLINICAL TRIAL UPDATE Read More